ZYME

Zymeworks Stock Analysis

AI Rating

Low
  • Quality4/10
  • Growth↑ 6/10
  • Value↓ 0/10
Zymeworks sales and earnings growth
ZYME Growth
Good
  • Revenue Y/Y↑ 38.87%
  • EPS Y/Y↑ 33.33%
  • FCF Y/Y↑ 69.19%
Zymeworks gross and profit margin trends
ZYME Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -76.60%
  • ROIC 5Y↓ -2.21%
Zymeworks net debt vs free cash flow
ZYME Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Zymeworks stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗